Genesis Clinical Research

Tampa, Florida 33614

3 studies enrolling now · 26 studies all time

What they study most

ADPKD, Atherosclerotic Cardiovascular Disease, Autoimmune and Chronic Inflammatory Diseases, Autosomal Dominant Polycystic Kidney, COVID-19, Chronic Kidney Diseases, Diabetes Mellitus, Type 2, Diabetic Nephropathies, Diabetic Peripheral Neuropathic Pain, End Stage Kidney Disease, Enteric Hyperoxaluria, Gout

Studies at this site

• Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease — Recruiting now
• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) — Recruiting now
• A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy — Recruiting now
• A Study to Learn About the Medicine Called PF-08653944 in People With and Without Reduced Liver Function — Recruiting now
• Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease — Recruiting now
• Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease — Running, not enrolling
• A Study of S-892216-PO in Participants With Renal Impairment and Matched Controls — Completed
• A Study to Learn How the Study Medicine Called Atirmociclib is Handled by the Body in People With Normal Liver Function and Different Levels of Liver Disease — Starting soon
• A Study of LY3537982 in Participants With Kidney Problems Compared With Participants With Normal Kidney Function — Completed
• A Study to Investigate the Pharmacokinetics and Safety of Remibrutinib in Participants With Severe Renal Impairment Compared to Matched Healthy Participants. — Completed
• A Study of RTA 901 (BIIB143) in Participants With Diabetic Peripheral Neuropathic Pain — Stopped early
• Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD) — Stopped early
• A Study of Apalutamide in Participants With Severe Hepatic Impairment Compared With Participants With Normal Hepatic Function — Completed
• Study of Nalbuphine HCl ER Tablets in Hemodialysis Patients With Uremic Pruritus — Completed
• Open Label Extension Study of Nalbuphine HCl ER in Hemodialysis Patients With Uremic Pruritus — Completed
• PK and Safety Evaluation Study of SAP-001 in Adult Subjects With Normal and Impaired Renal Function — Running, not enrolling
• A Study to Evaluate Pharmacokinetics (PK) and Safety of Inaxaplin in Participants With Renal Impairment — Completed
• Study of Pegloticase in Participants With Uncontrolled Gout Who Have Had a Kidney Transplant — Completed
• Evaluation of the Pharmacokinetics and Safety of VX-548 in Participants With Renal Impairment — Completed
• Safety and Tolerability of SYNB8802 in Healthy Adult Volunteers and Adult Subjects With Enteric Hyperoxaluria — Completed
• Study to Evaluate the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 (COVID-19) — Stopped early
• Study of the Efficacy and Safety of Tesevatinib in Subjects With ADPKD — Completed
• Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol) — Completed
• This Study Tests a New Medicine Called BI 685509 in Patients That Have Kidney Problems Because of Diabetes. The Study Tests How BI 685509 is Taken up in the Body and How Well it is Tolerated (Multiple Rising Doses) — Completed
• Treatment of Uremic Pruritus With PA101B — Completed
• Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment — Completed